Tuttle Capital Management’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Tuttle Capital Management’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,210	Closed	-$132K	–	134
2022 Q3	$132K	Sell	13,210 -16,956	-56%	-$169K	0.45%	69
2022 Q2	$298K	Sell	30,166 -11,531	-28%	-$114K	0.83%	54
2022 Q1	$411K	Sell	41,697 -14,121	-25%	-$139K	1.02%	42
2021 Q4	$547K	Sell	55,818 -20,544	-27%	-$202K	0.84%	54
2021 Q3	$749K	Sell	76,362 -21,186	-22%	-$209K	0.87%	47
2021 Q2	$965K	Sell	97,548 -32,742	-25%	-$330K	0.43%	84
2021 Q1	$1.34M	Buy	+130,290	New	+$1.45M	0.53%	55

Tuttle Capital Management's LUXA Position: Q4 2022 in Review

Tuttle Capital Management sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 13,210 shares — an estimated $132K sold.

Tuttle Capital Management first reported a position in LUXA in Q1 2021 and held it in 7 quarters. The position peaked at $1.34M in Q1 2021. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Tuttle Capital Management reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Tuttle Capital Management sold 13,210 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $132K.
Tuttle Capital Management first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
Tuttle Capital Management's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $1.34M in Q1 2021.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Tuttle Capital Management's 13F filing for Q4 2022, filed 25 Jan 2023.